Ask AI
ProCE Banner Activity

EngageTD: Workshop-Based Training in Tardive Dyskinesia Evaluation and Personalized Care

Slideset

Download this slideset developed by and tailored toward use by advanced practice providers to learn best practices for screening, assessing, and managing risk of tardive dyskinesia when treating patients with dopamine receptor–blocking agents such as antipsychotics

Released: June 22, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Teva.

Teva

Target Audience

This activity is intended for Nurse Practitioners, Nurses, Physician Assistants, and others involved in the care of patients with tardive dyskinesia who may benefit from this education.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement proactive risk-stratification and monitoring strategies to identify and counsel older adults or long-term antipsychotic-treated patients at heightened risk for TD

  • Apply validated screening tools and structured assessment protocols within routine clinical workflows to ensure timely detection, documentation, and follow-up of TD across diverse care settings

  • Evaluate the efficacy, safety, and tolerability profiles of FDA-approved VMAT2 inhibitors to individualize pharmacologic management of TD in older adults and special populations